Agentic Work Management solves the AI productivity gap; Organizations can run critical work with humans and agents on the same plan, with the same context, under the same governance Asana announces next generation AI Teammates purpose-built for industries and Asana Dash, an AI Chief of Staff for every user that knows your individual goals, priorities and what needs your attention New apps coming soon: Asana Service Management for IT, Command by Asana for Builders, and Asana Client Management for Professional Services Asana, Inc. (NYSE:ASAN)(LTSE: ASAN) today unveiled the operating system for human-agent teams: a new product suite designed to help organizations run critical work with h
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- Asana Unveils Operating System for Human-Agent Teams
- Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal
ST. GALLEN, Switzerland and LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, today announced a multi-year extension of its data and audiovisual (AV) betting rights agreement for The Championships, Wimbledon. The rights were originally secured as part of the company's acquisition of IMG ARENA in 2025. The multi-year renewal of the agreement beyond 2026 with the All England Club, which stages Wimbledon, continues Sportradar's exclusive global distribution of official data and AV betting rights. The agreement covers both The Championships main draw and the Qualif
- 111, Inc. Announces First Quarter 2026 Unaudited Financial Results
Continuing Transition toward a More Asset-Light and Operationally Efficient Business ModelNet Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-YearTotal Marketplace (MP) Service Revenue Increased by 24.7% Year-over-YearFulfillment Expenses as a Percentage of Revenue Improved by 10 Basis Points Year-over-YearSHANGHAI, June 4, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March
- Corona Launches 2026 Beach 100 Guide, Invites The World To Explore The Outdoors This Summer
Ahead of World Oceans Day, the global beach authority returns with a list of new locations, over 300,000 Tripadvisor experiences, and dedicated beach grants as part of its "This is Living" platform Corona, the world's most valuable beer brand1, today announced the return of its annual global beach guide, the 2026 Corona Beach 100, ahead of World Oceans Day on June 8. The highly anticipated second edition spotlights 100 breathtaking and varied ocean-front destinations around the world while celebrating the natural ecosystems and local communities that help bring them to life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026060
- Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO, ALVO-SDB)), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06, a proposed biosimilar to Eylea® (aflibercept) 2 mg. Under a partnership with Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Alvotech is responsible for the development and manufacturing of AVT05 and AVT06, while Teva is responsible for commercialization. The r
- WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
June 4, 2026 Seven-year collaboration puts WellSpan at the forefront of diagnostics and imaging in community health through a groundbreaking research and innovation strategy aimed at shaping the future of care delivery Amsterdam and YORK, Pa. – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, and WellSpan Health, the leading health care system in Central Pennsylvania and Northern Maryland, today announced a landmark seven-year strategic alliance that establishes a new research and innovation collaboration and brings new advanced imaging and diagnostics technology products and platforms to patients across the region. The alliance is the latest addition to WellSpan
- Expro Strengthens Longstanding Partnership With Deployment of Solus™ Technology in the Gulf of America
The multi-million-dollar agreement builds on a collaboration spanning more than two decades. Expro (NYSE:XPRO), a leading provider of energy services, has signed a new contract extension for up to five years, including the deployment of one of Expro's latest technologies, with a global operator to continue delivering subsea completion and intervention services in the Gulf of America (GoA) - reinforcing a partnership that has spanned more than two decades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604694670/en/Solus™ - Expro's Shear and Seal Valve Building on the success of recent projects this contract extension will i
- Kennedy Wilson and APG Form €2 Billion Residential Joint Venture to Develop and Manage over 3,400 Private Rented Homes in Ireland
Platform to develop three sites in Dublin, delivering approximately 2,300 new homes Kennedy Wilson (NYSE:KW), a global real estate investment company, announces the formation of a new residential joint venture with APG, on behalf of, amongst others, Dutch pension fund ABP, one of the world's largest pension investors, to create a €2 billion residential development and asset management platform. The venture will encompass more than 3,400 private rented homes across both operating and development assets, further strengthening Kennedy Wilson's position as the leader in residential real estate in the Irish market. Upon completion of the developments, Kennedy Wilson's owned and managed Irish p
- Aeva Technologies, Inc. Announces Pricing of Follow-On Offering
Aeva Technologies, Inc. (("Aeva" or the "Company", NASDAQ:AEVA), a leader in next-generation sensing and perception systems, today announced the pricing of its follow-on public offering of 4,494,382 shares of its common stock, at a price to the public of $22.25 per share. Closing of the offering is expected to occur on June 5, 2026, subject to customary closing conditions. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 674,157 shares of its common stock at the public offering price, less the underwriting discounts and commissions. The Company expects to use the net proceeds from the offering for general corporate purposes, including to
- JioHotstar Deepens Partnership with Magnite to Advance Programmatic Monetisation and Mediation Across Live Sports and Entertainment Portfolio
MUMBAI, India, June 04, 2026 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI) and its affiliates, together the largest independent sell-side advertising company, announced an expanded partnership with JioHotstar, India's biggest premium entertainment destination. As part of the collaboration, JioHotstar is leveraging Magnite's SpringServe to power advanced mediation across JioHotstar's live streaming, sports, and entertainment portfolio. JioHotstar is tapping into Magnite's mediation capabilities to maximise the value of their inventory. Magnite's technology provides JioHotstar with enhanced control and greater visibility into programmatic creatives, helping ensure consistent ad quality, support
- EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
Steroid use reduction and disease control: In additional results from the Phase 3 PHOENYCS GO study, dapirolizumab pegol (DZP) plus standard of care was associated with sustained disease control at lower glucocorticoid doses through Week 48 compared with placebo plus standard of care, supporting reduced long-term steroid exposureReduced flare rates and immune marker improvements: In other findings presented at EULAR 2026, improvements in immunological markers and reduced flare rates were observed, supporting the potential of dapirolizumab pegol to address the complex burden of SLE BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Bi
- WISeKey and Its Subsidiary WISeSat.Space Corp. Announce Confidential Submission of Amended Draft Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission
WISeKey and Its Subsidiary WISeSat.Space Corp. Announce Confidential Submission of Amended Draft Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission Canton of Zug, Switzerland— June 4, 2026 — WISeKey International Holding Ltd. ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and IoT, and its subsidiary WISeSat.Space Corp. ("WISeSat") today announced the confidential submission of an amended draft registration statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") on May 29, 2026 by WISeSat.Space Holdings Corp. ("Pubco"), a wholly-owned subsidiary of WISeSat. The draft registration statement
- Valneva Announces Availability of Documentation for its Annual General Meeting
Lyon (France), June 4, 2026 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company ("the Company"), today announced the availability of documentation for its Annual General Meeting ("the Meeting") to be held on June 25, 2026 at 2:00 p.m. CEST at the Sofitel Lyon Bellecour Hotel, 20 quai du Docteur Gailleton, 69002 Lyon (France). The Preliminary Notice of Meeting – including the agenda, the draft resolutions proposed by the Board of Directors, and instructions for participation and voting to the Meeting – was published in the Bulletin des Annonces Légales Obligatoires (BALO) on May 18, 2026. The information and preparatory documents related to this Meeting are available on Valne
- Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Supplemental New Drug Application (sNDA) resubmission seeks approval for 40 mg and 50 mg twice-daily dosingSeparate sNDA for lower weight pediatric patients planned for second half 2026 Leiden, the Netherlands, June 4, 2026: Pharming Group ((Euronext: PHARM, NASDAQ:PHAR) today announced that the U.S. Food and Drug Administration (FDA) has accepted its resubmitted supplemental New Drug Application (sNDA) seeking approval for Joenja® (leniolisib), an oral, selective phosphoinositide 3-kinase delta (PI3Kδ) inhi
- Ballard Power announces results of 2026 Annual General Meeting of Shareholders
VANCOUVER, BC, June 4, 2026 /CNW/ - Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) today announced results of its 2026 Annual General Meeting, which was held on June 3rd. Each of the Ballard directors was re-elected by a majority of the votes cast by shareholders present or represented by proxy.Director NomineeVotes For% ForVotes Withheld% WithheldKathy Bayless71,838,79998.211,312,5161.79Jacqueline Dedo72,258,61098.78892,7051.22Douglas P. Hayhurst66,168,32190.456,982,9949.55Hubertus M. Muehlhaeuser66,419,01590.806,732,3009.20Marty Neese72,533,02599.16618,2900.85James Roche66,824,15691.356,327,1598.65Ballard notes that Janet Woo
- Jade Biosciences Announces Pricing of Public Offering of Common Stock
SAN FRANCISCO and VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. ("Jade" or the "Company") (NASDAQ:JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the pricing of a public offering of 10,000,000 shares of its common stock. The shares of common stock are being sold to the public at a price of $15.00 per share. The gross proceeds to Jade from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $150.0 million, excluding any exercise of the underwriters' option to purchase additional shares. The offering
- 3D Systems Announces Pricing of $50 Million Upsized Public Offering
ROCK HILL, S.C., June 03, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems Corporation (NYSE:DDD) ("3D Systems") announced the pricing of its previously announced upsized underwritten public offering of 16,393,443 shares of common stock at a public offering price of $3.05 per share for total gross proceeds of approximately $50 million. All of the shares of common stock are being offered by 3D Systems. The offering is expected to close on June 5, 2026, subject to customary closing conditions. In addition, 3D Systems has granted the underwriters a 30-day option to purchase up to an additional 2,459,016 shares of common stock at the public offering price, less underwriting discounts and commissions
- Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC) ("Celcuity" or the "Company"), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the "Convertible Notes"). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000. The Company has granted the underwriters of the offering a 30-day option to purchase up to an additional $75,000,000 aggregate principal
- TEPCO Solution Advance Teams with Accenture to Reinvent Operations with AI
A five‑year, AI‑led reinvention program targets more than JPY 10 billion in cumulative value creation TEPCO Solution Advance Co., Ltd., the subsidiary of the Tokyo Electric Power Company Group responsible for providing operational services across the group, and Accenture (NYSE:ACN) today announced a strategic collaboration to reinvent its operating model by embedding AI and the latest digital technologies into the core of its business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603294994/en/(From left) Akira Tanahashi (President and Representative Director) and Tsuyoshi Numajiri (Director and Managing Executive Officer)
- BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., June 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the "Selling Stockholders"), including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain members of management, of an aggregate of 15,000,000 shares of common stock of BrightSpring, at the public offering price of $58.75 per share. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the pro